Gregory Verdine
Harvard's Gregory Verdine has big ambitions for his miniprotein 'braces' — and now $107M to guide them to the clinic
Harvard scientist Gregory Verdine’s mission has always been clear: drug the undruggable. He’s now one step closer, with $107 million in the bank to bring …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
